Candida auris (also referred to as Candidozyma auris) is an emerging multidrug-resistant fungal pathogen associated with high morbidity and mortality, with limited infection prevention and control (IPC) guidance available for pediatric settings. A multidisciplinary expert panel convened by the Society for Healthcare Epidemiology of America (SHEA) developed these recommendations using a structured Delphi consensus process informed by published literature, expert judgment, and practical considerations. This consensus statement provides pediatric-specific IPC recommendations for acute care, non-acute healthcare, and non-healthcare congregate settings, addressing screening, isolation, caregiver–child interactions, environmental cleaning, shared equipment, and other key considerations. Together, the recommendations provide a practical framework to support prevention of C. auris transmission while recognizing the unique clinical, developmental, and family-centered needs of children.
Authors: Thomas S. Murray, Hana Hakim, Christelle Ilboudo, Lynn Ramírez-Ávila, Jana Shaw, Terri Stillwell, Patricia Budo, Bernard Ebruke, Noa Fleiss, Amanda Green, Matthew Linam, Roshni Mathew, April McDougal, Natalie Neu, Zoi Dorothea Pana, Karen Ravin, Ayelet Rosenthal, Jane D. Siegel, Katlyn Stiemel, Amy Valencia, Carol Vance, Lars F. Estblade, Lisa Saiman.